Large cell carcinoma of the lung future or investigational therapies

Large Cell Carcinoma of the Lung Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Large Cell Carcinoma of the Lung from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Radiation Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Large cell carcinoma of the lung future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Large cell carcinoma of the lung future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Large cell carcinoma of the lung future or investigational therapies
CDC on Large cell carcinoma of the lung future or investigational therapies
Large cell carcinoma of the lung future or investigational therapies in the news
Blogs on Large cell carcinoma of the lung future or investigational therapies
Directions to Hospitals Treating Large cell carcinoma of the lung
Risk calculators and risk factors for Large cell carcinoma of the lung future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Future or Investigational Therapies

Novel trials of large cell carcinoma of the lung, include:

• Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.

References

Template:WikiDoc Sources